Tekla Capital Management LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 162 filers reported holding KURA ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q1 2023$3,464,527
-1.5%
283,2810.0%0.13%
-0.8%
Q4 2022$3,515,517
-31.4%
283,281
+3.6%
0.13%
-19.4%
Q3 2021$5,122,000
-10.2%
273,4630.0%0.16%
-10.8%
Q2 2021$5,702,000
-26.2%
273,4630.0%0.18%
-30.5%
Q1 2021$7,731,000
-13.4%
273,4630.0%0.27%
-15.3%
Q4 2020$8,931,000
+391.3%
273,463
+360.8%
0.31%
+361.8%
Q3 2020$1,818,00059,3390.07%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,766,852$57,633,0006.49%
GREAT POINT PARTNERS LLC 2,197,283$33,618,0005.74%
Sio Capital Management, LLC 392,027$5,998,0003.38%
BVF INC/IL 1,353,846$20,714,0002.50%
Boxer Capital, LLC 844,789$12,925,0002.36%
ALETHEA CAPITAL MANAGEMENT, LLC 89,673$1,372,0002.18%
Minerva Advisors LLC 170,921$2,607,0001.41%
NEXTHERA CAPITAL LP 445,550$6,817,0001.26%
DAFNA Capital Management LLC 117,281$1,794,0000.97%
PFM Health Sciences, LP 1,752,124$26,807,0000.64%
View complete list of KURA ONCOLOGY INC shareholders